Drug recall · December 21, 2022
8.4% Sodium Bicarbonate Injection recall
Why: Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1.
- Lots / codes
Lots: P0001178 Exp. 05/2023; P0001298, P0001301, P0001313, P0001314, P0001317 Exp. 08/2023; P0001330, P0001464 Exp. 09/2023; P0001442 Exp. 11/2023; P0001467, P0001472, P0001486, P0001532 Exp. 12/2023.
- Quantity
- 489,600 vials
- Company
- Exela Pharma Sciences LLC, Lenoir, NC
- Distribution
- Nationwide within the United States
- Initiated
- November 28, 2022 · Voluntary: Firm initiated
- Classified
- December 13, 2022
- Reported
- December 21, 2022
- Ended
- October 10, 2025
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium bicarbonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.